VATRELLA, Alessandro
 Distribuzione geografica
Continente #
AS - Asia 19.487
NA - Nord America 15.810
EU - Europa 4.963
SA - Sud America 964
Continente sconosciuto - Info sul continente non disponibili 482
AF - Africa 153
OC - Oceania 17
Totale 41.876
Nazione #
US - Stati Uniti d'America 15.505
HK - Hong Kong 13.519
SG - Singapore 2.522
IT - Italia 2.091
CN - Cina 1.340
VN - Vietnam 920
BR - Brasile 737
UA - Ucraina 687
DE - Germania 466
RU - Federazione Russa 453
FR - Francia 277
IE - Irlanda 271
TR - Turchia 263
KR - Corea 211
FI - Finlandia 181
SE - Svezia 178
IN - India 158
BD - Bangladesh 153
CA - Canada 144
GB - Regno Unito 124
AR - Argentina 85
MX - Messico 64
IQ - Iraq 56
JP - Giappone 53
TW - Taiwan 49
ZA - Sudafrica 46
NL - Olanda 41
ES - Italia 36
EC - Ecuador 35
CO - Colombia 33
AT - Austria 31
ID - Indonesia 31
PL - Polonia 29
PK - Pakistan 28
UZ - Uzbekistan 26
VE - Venezuela 22
CR - Costa Rica 21
PH - Filippine 21
JM - Giamaica 20
LT - Lituania 19
TN - Tunisia 19
MA - Marocco 18
MY - Malesia 18
SA - Arabia Saudita 17
AU - Australia 16
DZ - Algeria 15
KE - Kenya 14
NP - Nepal 13
CZ - Repubblica Ceca 12
PE - Perù 12
PY - Paraguay 12
TT - Trinidad e Tobago 12
AZ - Azerbaigian 10
BE - Belgio 10
CL - Cile 10
EG - Egitto 10
JO - Giordania 9
UY - Uruguay 9
EU - Europa 8
BG - Bulgaria 7
BH - Bahrain 7
ET - Etiopia 7
HN - Honduras 7
KZ - Kazakistan 7
AE - Emirati Arabi Uniti 6
NI - Nicaragua 6
OM - Oman 6
RO - Romania 6
SV - El Salvador 6
TH - Thailandia 6
BO - Bolivia 5
GR - Grecia 5
IL - Israele 5
LB - Libano 5
PT - Portogallo 5
AL - Albania 4
BB - Barbados 4
EE - Estonia 4
GT - Guatemala 4
GY - Guiana 4
KG - Kirghizistan 4
KW - Kuwait 4
NG - Nigeria 4
BY - Bielorussia 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
LU - Lussemburgo 3
PA - Panama 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
AM - Armenia 2
BS - Bahamas 2
BZ - Belize 2
CU - Cuba 2
DK - Danimarca 2
GE - Georgia 2
IR - Iran 2
MD - Moldavia 2
Totale 41.361
Città #
Hong Kong 13.508
Ann Arbor 2.573
San Jose 1.341
Singapore 1.318
Wilmington 1.148
Woodbridge 1.121
Ashburn 1.022
Jacksonville 856
Milan 852
Chandler 851
Princeton 754
Dallas 580
Houston 574
Council Bluffs 552
Dong Ket 397
Beijing 325
Dublin 266
The Dalles 238
Lauterbourg 233
Izmir 226
Ho Chi Minh City 179
Rome 177
Moscow 169
Andover 166
Nanjing 159
Munich 154
Santa Clara 154
Boardman 141
Dearborn 134
São Paulo 128
New York 126
Pellezzano 125
Hanoi 120
Los Angeles 114
Naples 102
Salerno 95
Mestre 81
Düsseldorf 65
Phoenix 65
Fairfield 64
Figino 64
Shenyang 54
Hebei 52
Memphis 52
Changsha 51
Tokyo 48
Turin 47
Toronto 46
Frankfurt am Main 45
Chicago 43
Helsinki 43
Taipei 43
Nanchang 42
Norwalk 42
Orem 42
Atlanta 41
Columbus 39
Jiaxing 39
Redwood City 35
Pune 34
Tianjin 34
Montreal 33
Brooklyn 31
Seattle 31
Johannesburg 29
Nuremberg 29
Denver 28
Da Nang 27
San Francisco 27
Mexico City 26
Baghdad 25
Rio de Janeiro 25
Shanghai 25
Warsaw 25
Boston 24
Haiphong 24
Jinan 24
Washington 24
Dhaka 23
Falls Church 23
Tashkent 22
Stockholm 21
London 20
Manchester 20
Amsterdam 19
Florence 19
Mumbai 19
Vienna 19
Cambridge 18
Charlotte 18
Brasília 17
Chennai 17
Pollena Trocchia 16
Bologna 15
Las Vegas 15
Miami 15
New Delhi 15
San Diego 15
San José 15
Belo Horizonte 14
Totale 33.041
Nome #
Omalizumab decreases exacerbation frequency, oral intake of corticosteroids and peripheral blood eosinophils in atopic patients with uncontrolled asthma. 2.395
Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project) 981
Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study 909
Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications 832
Sustained remission induced by 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and nasal polyposis 714
Surgical approach in thymectomy: Our experience and review of the literature 631
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study 604
Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control 581
Role of FDG-PET scan in staging of pulmonary epithelioid hemangioendothelioma 579
Eosinophilic inflammation: An Appealing Target for Pharmacologic Treatments in Severe Asthma 577
Inhibitory effects of the IL-6 receptor superantagonist SANT7 on MAP kinase phosphorylation and cell proliferation induced by IL-6 and TGF-beta1in human lung fibroblasts 507
Effects of inhaled beclomethasone dipropionate/formoterol fumarate/glycopyrronium on diaphragmatic workload and lung function in uncontrolled asthma: a case report 489
Effects of statins and farnesyltransferase inhibitors on proliferation and ERK phosphorylation in non-small lung cancer cells. 459
Short-term evaluation of dupilumab effects in patients with severe asthma and nasal polyposis 443
The precision medicine strategy to treat COPD pulmonary traits in clinical practice: The role of N-acetylcysteine 443
Phenotyping severe asthma: a rationale for biologic therapy 437
Application of Proteomics and Peptidomics to COPD 385
Extrathoracic recurrence of type A thymoma 369
Severe eosinophilic asthma: From the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab 364
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma 330
Bone and soft tissue non-Hodgkin lymphoma of the maxillofacial area: report of two cases, literature review and new therapeutic strategies. 325
Use of narrative medicine to identify key factors for effective doctor-patient relationships in severe asthma 318
Differential expression of RNA-binding proteins in bronchial epithelium of stable COPD patients 317
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness 305
Social Networks, Asthma and Much More.. 303
Role of p38-mitogen-activated protein kinase in COPD: pathobiological implications and therapeutic perspectives 289
Novel Biological Therapies for Severe Asthma Endotypes 248
Expression of targets of the RNA-binding protein AUF-1 in human airway epithelium indicates its role in cellular senescence and inflammation 247
Asymmetric dimethylarginine (ADMA): Will be or will not be a new revolutionary biomarker of bronchial asthma? 228
Pharmacotherapeutic strategies for critical asthma syndrome: a look at the state of the art 209
Effects of TGF-beta and budesonide on MAPK phosphorylation, IL-6/IL-11 secretion, and cell proliferation in human lung fibroblasts 204
A case of pulmonary hemangioendothelioma transformed into an epitheliod angiosarcoma. 196
Role of biologics in severe eosinophilic asthma – focus on reslizumab 193
Vascular remodeling in bronchial mucosa of smokers with and without airway obstruction. 191
Differential expression of RNA-binding proteins in airway epithelium in chronic lung inflammation 188
Angiogenetic and apoptotic process in the airways of symptomatic smokers with and without a contralateral non small cell lung cancer 187
Angiogenesis in Bronchial Biopsies of Symptomatic Smokers with and without Lung Cancer 185
Age as a risk factor in the occurrence of pneumothorax after transthoracic fine needle biopsy: our experience 183
Protective effect of MAPK inhibitors and budesonide against apoptosis induced by TGF- in primary cultures of human bronchial epithelial cells. 179
Effects of budesonide on p38 MAPK activation, apoptosis and IL-8 secretion, induced by TNF-alpha and Haemophilus influenzae in human bronchial epithelial cells 179
Respiratory infections and asthma 178
A single-blind, partial crossover clinical trial of the effects of inhaled fluticasone propionate and nedocromil sodium on airway hyperresponsiveness to methacholine 176
Effects of endothelin-1 on MAPK activation, IL-6 production and cell proliferation in normal human lung fibroblasts 176
Characterization of peripheral subsets of dendritic cells in COPD patients: preliminary data 176
Treating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a review 173
Serum eosinophil cationic protein (ECP) as a marker of disease activity and treatment efficacy in seasonal asthma. 171
An Acute Bronchodilator Test with Tiotropium or Salmeterol Does Not Allow a Subdivision of Patients according to Responses 171
Detection of RAS mutation by pyrosequencing in thyroid cytology samples 168
Long-term treatment in pediatric asthma: an update on chemical pharmacotherapy 168
Bronchial vascularity in the airways of chronic bronchitis and COPD smokers 166
Cushing's like syndrome in typical bronchial carcinoid a case report and review of the literature 165
P38 signalling pathway in primary cultures of human bronchial epithelial cells: effects of transforming growth factor-β and pharmacological modulation by budesonide 163
Allergy in urban elderly population living in Campania region (Southern Italy). A multicenter study 162
Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis 161
The role of calcium blockers in asthma prevention and therapy. 161
[Netilmicin in the treatment of respiratory infections]. 160
Potential role of potassium channel openers in the treatment of asthma and chronic obstructive pulmonary disease. 157
[The lung in connectivitis]. 155
Bronchodilating effects of salmeterol, theophylline and their combination in patients with moderate to severe asthma. 154
Asthma: Targeted biological therapies 154
Negative and Positive Role of Social Network in Asthma Patients 154
Negative and positive role of social network in asthma patients 154
Comparison of the bronchodilating effects of inhaled formoterol, salmeterol and salbutamol in asthmatic patients. 151
The effects of adding formoterol (F) and tiotropium (T) on exercise performance and breathlessness in patients with COPD 151
Surgical management of cervico-mediastinal goiters: Our experience and review of the literature 151
Molecular mechanisms of corticosteroid actions in chronic inflammatory airway diseases. 150
Protective effect of levodropropizine against cough induced by inhalation of nebulized distilled water in patients with obstructive lung disease. 150
Vascular remodelling in COPD airways 150
Asthma-related deaths 149
An insight into pharmacological and clinical basis of anti-IgE for add-on therapy of severe asthma 148
Inhaled beclomethasone dipropionate (BDP) prevents seasonal changes in atopic asthmatics. 147
Small cell lung cancer associated with solitary fibrous tumors of the pleura: A case study and literature review 147
Climate change and air pollution: Effects on respiratory allergy 147
Airway Remodelling in Asthma 146
SIRT1 Activity in Peripheral Blood Mononuclear Cells Correlates with Altered Lung Function in Patients with Chronic Obstructive Pulmonary Disease 146
Effects of transforming growth factor-[beta] and budesonide on mitogen-activated protein kinase activation and apoptosis in airway epithelial cells. 145
The potential of biologics for the treatment of asthma 145
New treatments for asthma: From the pathogenic role of prostaglandin D2 to the therapeutic effects of fevipiprant 145
Update on effects of climate changes on respiratory allergy 143
Allergenic pollen and pollen allergy in Europe 143
New perspectives in asthma treatment. 142
[Heterogeneity of microbial flora responsible for respiratory infections in AIDS]. 142
Sirtuin 1 and aging theory for chronic obstructive pulmonary disease 142
Comparative effects of a two-week treatment with nebivolol and nifedipine in hypertensive patients suffering from COPD. 141
Cytological diagnosis of the thyroidal nodule: A review 141
Exhaled nitric oxide after inhalation of isotonic and hypotonic solutions in healthy subjects. 140
[A case of pulmonary fibrosis]. 139
Fine-needle cytology in the follow-up of breast carcinoma 139
Effects of hydrogen peroxide on MAPK activation, IL-8 production and cell viability in primary cultures of human bronchial epithelial cells. 138
Audit on the appropriateness of integrated COPD management: The "aLT-BPCO" project 138
COPD: Maximization of bronchodilation 138
Near fatal asthma: Treatment and prevention 138
Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems 138
Increased activation of p38 MAPK in COPD 137
Inhibitory effects of budesonide on MAPK activation and apoptosis induced by TGF-beta in primary cultures of human bronchial epithelial cells 137
Endothelin-1 induces proliferation of human lung fibroblasts and IL-11 secretion through an ET(A) receptor-dependent activation of MAP kinases. 137
[The role of neutrophils in the pathogenesis of chronic pulmonary emphysema]. 137
Recurrent respiratory infections caused by a double aortic arch: The diagnostic role of spirometry 137
Activation of the AIM2 Receptor in Circulating Cells of Post-COVID-19 Patients With Signs of Lung Fibrosis Is Associated With the Release of IL-1α, IFN-α and TGF-β 134
Post-pneumonectomy broncho-pleural fistula successfully closed by open-window thoracostomy associated with V.A.C. therapy. 134
Totale 26.749
Categoria #
all - tutte 116.756
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 116.756


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.263 0 0 0 18 23 43 25 55 186 163 170 580
2022/20232.072 220 131 61 255 254 465 8 210 308 19 98 43
2023/20241.019 99 130 62 61 60 131 50 101 14 51 41 219
2024/20253.225 69 57 47 99 104 316 422 286 452 183 244 946
2025/202622.023 4.419 5.535 4.182 604 1.183 567 1.828 355 534 1.152 308 1.356
2026/20272.567 371 313 981 902 0 0 0 0 0 0 0 0
Totale 41.876